Frederick H Reynolds, Jr

Title: The Innovations of Frederick H Reynolds, Jr.

Introduction

Frederick H Reynolds, Jr. is a notable inventor based in Syosset, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of immunoassays and monoclonal antibodies. With a total of three patents to his name, his work has had a substantial impact on medical diagnostics.

Latest Patents

One of his latest patents is an immunoassay for the detection of mutant P53 polypeptide in serum. This invention plays a crucial role in cancer diagnostics. Another significant patent involves monoclonal antibodies recognizing parathyroid hormone-like protein. This invention provides a monoclonal antibody that specifically forms a complex with amino acids 1-87 of PTHLP, which does not form a complex with amino acids 1-34 of PTHLP. It also includes methods for detecting PTHLP and diagnosing and treating humoral hypercalcemia of malignancy.

Career Highlights

Throughout his career, Frederick has worked with prominent companies in the biotechnology sector, including Oncogene Science, Inc. and Osi Pharmaceuticals, Inc. His work in these organizations has contributed to advancements in medical research and therapeutic development.

Collaborations

Frederick has collaborated with notable professionals in his field, including John M Sorvillo and David M Valenzuela. These collaborations have further enhanced the quality and impact of his inventions.

Conclusion

Frederick H Reynolds, Jr. is a distinguished inventor whose work in immunoassays and monoclonal antibodies has significantly advanced medical diagnostics. His contributions continue to influence the field of biotechnology and improve patient outcomes.